Site Tops

:: Most studied contents
Editorial Board ( 16306 view)
About Journal ( 13210 view)
Is COVID-19 Risk Linked to Blood Type? ( 8408 view)
Submission Instruction ( 8266 view)
Indexing &Abstracting ( 7767 view)
Aims and Scope ( 7740 view)
Editorial policies ( 7585 view)
Contact us ( 6952 view)
Invition for papers ( 5672 view)
Peer Review policy ( 5314 view)
Ethical Principles for Psychological Research ( 4576 view)
Call for Paper: Special Issue on COVID-19 Pandemic ( 1854 view)
Open Access Policy ( 1641 view)
CrossMark Policy ( 1565 view)
Policies of Peer Review ( 1326 view)
Registration Information ( 1122 view)
What do we know for sure about hydroxychloroquine for COVID-19? Not much ( 959 view)
Publishing Ethics ( 957 view)
Financial Policies ( 954 view)
Financial Policies ( 948 view)
COVID-19 resources: serological tests, face masks and benefits of physical activity ( 929 view)
Webinars for the Week of July 6th ( 902 view)
FDA approves generic albuterol inhaler to mitigate shortages during pandemic ( 891 view)
Ethical Principles for Medical Research ( 885 view)
Reviewers List ( 861 view)
COVID-19: Bacteriophage Could Decrease Mortality ( 858 view)
Animal Models of COVID-19 ( 820 view)
Social isolation can lead to depression in children long after current lockdown ( 777 view)
Introduction to testing for COVID-19 ( 730 view)
Conflicts of Interest ( 712 view)
Prospective randomized trial of interventions for vincristine-related neuropathic pain ( 633 view)
Upcoming Events of the ACSE ( 593 view)
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US ( 553 view)
Pharmaceutical and Biomedical Research ( 527 view)
Hologic Showcased Latest Advances at Virtual ECR Congress 2020 ( 482 view)
From Brain to Behavior: The Search for Biomarkers ( 352 view)
Happy Peer Review Week from ACS Publications ( 293 view)
Share your COVID experiences with 2 million+ researchers ( 268 view)
International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy ( 135 view)
Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial ( 101 view)

© 2020 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb